MX2007003609A - Formulacion liquida de vacuna para alergia para la administracion oromucosal. - Google Patents

Formulacion liquida de vacuna para alergia para la administracion oromucosal.

Info

Publication number
MX2007003609A
MX2007003609A MX2007003609A MX2007003609A MX2007003609A MX 2007003609 A MX2007003609 A MX 2007003609A MX 2007003609 A MX2007003609 A MX 2007003609A MX 2007003609 A MX2007003609 A MX 2007003609A MX 2007003609 A MX2007003609 A MX 2007003609A
Authority
MX
Mexico
Prior art keywords
oromucosal administration
vaccine formulation
allergy vaccine
liquid
liquid allergy
Prior art date
Application number
MX2007003609A
Other languages
English (en)
Spanish (es)
Inventor
Jens Brimnes
Jens Kildsgaard
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk Abello As filed Critical Alk Abello As
Publication of MX2007003609A publication Critical patent/MX2007003609A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MX2007003609A 2004-09-27 2005-09-22 Formulacion liquida de vacuna para alergia para la administracion oromucosal. MX2007003609A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61389204P 2004-09-27 2004-09-27
DKPA200401468 2004-09-27
PCT/DK2005/000601 WO2006034707A1 (en) 2004-09-27 2005-09-22 Liquid allergy vaccine formulation for oromucosal administration

Publications (1)

Publication Number Publication Date
MX2007003609A true MX2007003609A (es) 2007-06-05

Family

ID=35431828

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007003609A MX2007003609A (es) 2004-09-27 2005-09-22 Formulacion liquida de vacuna para alergia para la administracion oromucosal.

Country Status (16)

Country Link
US (1) US20060115499A1 (https=)
EP (1) EP1793853B1 (https=)
JP (1) JP4976298B2 (https=)
KR (1) KR20070057963A (https=)
CN (1) CN101048176B (https=)
AT (1) ATE421330T1 (https=)
AU (1) AU2005289193A1 (https=)
CA (1) CA2581815A1 (https=)
DE (1) DE602005012522D1 (https=)
DK (1) DK1793853T3 (https=)
ES (1) ES2321425T3 (https=)
IL (1) IL182135A0 (https=)
MX (1) MX2007003609A (https=)
NO (1) NO20071636L (https=)
RU (1) RU2007115920A (https=)
WO (1) WO2006034707A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1814516B1 (en) * 2005-11-04 2012-12-26 Alk-Abelló A/S Use of a liquid allergy vaccine formulation for oromucosal administration
DK1974745T3 (da) * 2007-03-28 2011-11-28 Alk Abello As Anvendelse af en adjuvansholdig allergivaccineformulering til subkutan administration
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
US8491911B2 (en) * 2008-10-15 2013-07-23 Alk-Abello A/S Pharmaceutical product for up-dosing of allergy vaccine
WO2010127144A1 (en) 2009-04-29 2010-11-04 Muniyappa Pravin K Device and method for the diagnosis of gastrointestinal allergy
CN106421775B (zh) * 2015-08-12 2020-12-01 普莱柯生物工程股份有限公司 一种疫苗用佐剂及含该佐剂的疫苗组合物和其应用
AU2017279647B2 (en) 2017-02-15 2022-05-26 Euroimmun Medizinische Labordiagnostika Ag An improved assay for the diagnosis of peanut allergy

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148121A (en) * 1960-01-27 1964-09-08 Miles Lab Water-insoluble whole inhalant complex and method of making same
US3329564A (en) * 1965-06-28 1967-07-04 Parke Davis & Co Antacid preparations and means of producing the same
US4233288A (en) * 1979-03-12 1980-11-11 Cornell John A Gum emulsified liquid package for delivering and preserving liquid content in the mouth
US4341763A (en) * 1981-03-10 1982-07-27 Smithkline-Rit Methods of vaccinating humans against rotavirus infection
JPS61238728A (ja) * 1985-04-16 1986-10-24 Mitsui Norin Kk 茶葉抽出物と活性水酸化アルミニウムとの抗潰瘍性複合体
US6103243A (en) * 1985-05-15 2000-08-15 Biotechnology Australia Pty, Ltd Oral vaccines
KR900701304A (ko) * 1988-05-05 1990-12-01 루이즈 츄이 콜린스 에이미 사람 및/또는 동물용 알레르겐 탈감작제
US5032405A (en) * 1989-09-27 1991-07-16 Warner-Lambert Company Oral pharmaceutical composition for acid sensitive proteinaceous agents
US5443832A (en) * 1990-04-16 1995-08-22 Institut Swisse De Recherches Experimentales Sur Le Cancer Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
JP3414539B2 (ja) * 1994-05-11 2003-06-09 有限会社ドット 経鼻吸収用組成物
US5985312A (en) * 1996-01-26 1999-11-16 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US20020068090A1 (en) * 1999-02-03 2002-06-06 Bell Steve J. D. Calcium phosphate particles as mucosal adjuvants
CA2361377C (en) * 1999-02-05 2009-02-03 Alk-Abello A/S Novel mucosal delivery system
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
DK2116257T3 (da) * 2000-08-09 2013-02-04 Alk Abello As Parenterale vaccineformuleringer og anvendelser deraf
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
ATE414773T1 (de) * 2000-11-16 2008-12-15 Alk Abello As Mutante allergene
CN1668737A (zh) * 2002-05-16 2005-09-14 阿尔克-阿贝洛有限公司 重组Bet.V.1过敏原突变体及其方法和制备
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product

Also Published As

Publication number Publication date
DE602005012522D1 (de) 2009-03-12
CN101048176A (zh) 2007-10-03
EP1793853B1 (en) 2009-01-21
NO20071636L (no) 2007-06-14
JP2008514557A (ja) 2008-05-08
HK1106447A1 (en) 2008-03-14
AU2005289193A1 (en) 2006-04-06
ATE421330T1 (de) 2009-02-15
JP4976298B2 (ja) 2012-07-18
RU2007115920A (ru) 2008-11-10
CA2581815A1 (en) 2006-04-06
CN101048176B (zh) 2012-01-11
WO2006034707A1 (en) 2006-04-06
ES2321425T3 (es) 2009-06-05
IL182135A0 (en) 2007-07-24
DK1793853T3 (da) 2009-04-14
EP1793853A1 (en) 2007-06-13
KR20070057963A (ko) 2007-06-07
US20060115499A1 (en) 2006-06-01

Similar Documents

Publication Publication Date Title
IL182135A0 (en) Liquid allergy vaccine formulation for ormucosal administration
WO2009086112A3 (en) Apparatus and methods for delivering therapeutic agents
EP1676512A3 (en) Skin treatment articles and methods
WO2007147019A3 (en) Il-17 and il-23 antagonists and methods of using the same
WO2009074735A3 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
WO2006060507A3 (en) Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders
MY162248A (en) Hydrophilic coating
WO2006086107A3 (en) Methods and compositions for minimizing accrual of inhalable insulin in the lungs
WO2005102338A8 (en) Method of treating neuropathic pain using a crth2 receptor antagonist
TW200621268A (en) Antimicrobial copolymers and uses thereof
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
ZA200808465B (en) Pharmaceutical formulations:salts of 8-[{1-(3,5-bis (trifluoromethy1)pheny1)-e thoxy}-methy1]-8-pheny1-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
BRPI0415164A (pt) dispositivo para administrar uma composição bioterapêutica, composição bioterapêutica, método de preparação de uma composição bioterapêutica, método de tratamento, e dispensador
WO2007011955A3 (en) Drug-containing implants and methods of use thereof
EP3305305A3 (en) Silicate containing compositions and methods of treatment
WO2007067519A3 (en) The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
NO20081147L (no) Marrubiin og preparat for redusering av snorking, forpakning og metode
WO2005107753A3 (en) Naltrexone long acting formulations and methods of use
WO2005082781A3 (en) Method for preparing adjustably bioresorbable sol-gel derived sio2
EP1603595A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRUG INDEPENDENCE
IL182297A (en) Use of winter savory (satureja montana) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation
WO2007084964A3 (en) Pharmaceutical composition comprising a protein pump inhibitor and protein component
PL1874410T3 (pl) Odbarwiająca lub rozjaśniająca kompozycja kosmetyczna zawierająca co najmniej jedną oksazolinę jako składnik aktywny
WO2006044548A3 (en) Clopidogrel compositions
WO2007077454A3 (en) A therapeutic composition comprising an inhibitor of an hsp 90 protein